Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
Pulmonx (Nasdaq: LUNG), a leader in minimally invasive treatments for severe lung disease, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company will engage in a fireside chat on Wednesday, December 4, 2024, at 9:30 AM PT / 12:30 PM ET in New York. Interested parties can access both live and archived webcasts of the presentation through the 'Investors' section of the Pulmonx website.
Pulmonx (Nasdaq: LUNG), leader nei trattamenti minimally invasive per gravi patologie polmonari, ha annunciato la sua partecipazione alla 36ª Conferenza Sanitaria Annuale Piper Sandler. L'azienda parteciperà a una conversazione informale mercoledì 4 dicembre 2024, alle 9:30 PT / 12:30 ET a New York. Le parti interessate possono accedere sia alle dirette che alle registrazioni degli webcast della presentazione attraverso la sezione 'Investitori' del sito web di Pulmonx.
Pulmonx (Nasdaq: LUNG), líder en tratamientos mínimamente invasivos para enfermedades pulmonares severas, ha anunciado su participación en la 36ª Conferencia Anual de Salud Piper Sandler. La empresa participará en una charla informal el miércoles 4 de diciembre de 2024, a las 9:30 AM PT / 12:30 PM ET en Nueva York. Las partes interesadas pueden acceder a las transmisiones en vivo y grabadas de la presentación a través de la sección 'Inversores' en el sitio web de Pulmonx.
Pulmonx (Nasdaq: LUNG), 중증 폐 질환을 위한 최소 침습 치료의 선두주자가, Piper Sandler 제36회 연례 의료 콘퍼런스에 참여한다고 발표했습니다. 회사는 2024년 12월 4일 수요일 오후 9시 30분 PT / 오후 12시 30분 ET 뉴욕에서 화상 대화에 참여할 예정입니다. 관심 있는 분들은 Pulmonx 웹사이트의 '투자자' 섹션을 통해 발표의 생중계 및 녹화된 웹캐스트 모두에 접근할 수 있습니다.
Pulmonx (Nasdaq: LUNG), leader dans les traitements peu invasifs pour les maladies pulmonaires graves, a annoncé sa participation à la 36ème Conférence Annuelle sur la Santé de Piper Sandler. L'entreprise s'engagera dans une discussion informelle le mercredi 4 décembre 2024, à 9h30 PT / 12h30 ET à New York. Les parties intéressées peuvent accéder aux webcasts en direct et archivés de la présentation via la section 'Investisseurs' du site web de Pulmonx.
Pulmonx (Nasdaq: LUNG), führend in minimalinvasiven Behandlungen für schwere Lungenerkrankungen, hat seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler angekündigt. Das Unternehmen wird am Mittwoch, den 4. Dezember 2024, um 9:30 Uhr PT / 12:30 Uhr ET in New York an einem Kamin-Gespräch teilnehmen. Interessierte können sowohl auf die Live- als auch auf die aufgezeichneten Webcasts der Präsentation über den Bereich 'Investoren' der Pulmonx-Website zugreifen.
- None.
- None.
REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference in New York on Wednesday, December 4, 2024, at 9:30 AM PT / 12:30 PM ET.
A live and archived webcast of the presentation will be available on “Investors” section of the Pulmonx website at https://investors.pulmonx.com/.
About Pulmonx Corporation
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System, LungTraX™ Platform, and StratX® Lung Analysis Report are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market approval to commercialize the Zephyr Valve following its designation as a “breakthrough device.” The Zephyr Valve is commercially available in more than 25 countries, is included in global treatment guidelines and is widely considered a standard of care treatment option for improving breathing, activity and quality of life in patients with severe emphysema. For more information on the Zephyr Valves and the company, please visit www.Pulmonx.com.
Contact
Brian Johnston
Gilmartin Group
investors@pulmonx.com
FAQ
When is Pulmonx (LUNG) presenting at the Piper Sandler Healthcare Conference 2024?
How can I watch Pulmonx's (LUNG) presentation at the Piper Sandler Conference?
What type of presentation will Pulmonx (LUNG) give at the Piper Sandler Healthcare Conference?
Where is the Piper Sandler Healthcare Conference 2024 being held for Pulmonx (LUNG)?
